1
|
[An improved association analysis pipeline for tumor susceptibility variant in haplotype amplification area]. NAN FANG YI KE DA XUE XUE BAO = JOURNAL OF SOUTHERN MEDICAL UNIVERSITY 2020; 40:1493-1499. [PMID: 33118521 PMCID: PMC7606235 DOI: 10.12122/j.issn.1673-4254.2020.10.16] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
OBJECTIVE Haplotype amplification on germline variants is suggested to imply potential selective advantages and clonal expansion susceptibility and has become an important signature for seeking cancer susceptibility gene.Here we propose an improved association method that fully considers the haplotype amplification status. METHODS The haplotype amplification status was estimated by the variant allelic frequencies.We adopted a permutation test on variant allelic frequencies to divide the candidate variants into multiple groups.A likelihood clustering method was then applied to establish the neighborhood system of the hidden Markov random field framework.A filtering pipeline was introduced into the proposed method to further refine the candidate variants, including a Wilson's interval filter and a false discovery rate controller.The final candidate set along with the haplotype amplification status was collapsed into the weighted virtual sites for association tests. RESULTS Through simulated tests on a series of datasets, we compared the type Ⅰ error rates of different minor allele frequencies, which stably fell within 2%, suggesting good robustness of the algorithm.In addition, we compared another 5 published association approaches for Type-Ⅰ and Type-Ⅱ error rates with the proposed method, which resulted in the error rates all within 2%, demonstrating significant advantages and a good statistical ability of the proposed method. CONCLUSIONS The proposed method can accurately identify tumor susceptibility variants in haplotype amplification area with good robustness and stability.
Collapse
|
2
|
Geng Y, Zhao Z, Zhang X, Wang W, Cui X, Ye K, Xiao X, Wang J. An improved burden-test pipeline for identifying associations from rare germline and somatic variants. BMC Genomics 2017. [PMID: 29513197 PMCID: PMC5657102 DOI: 10.1186/s12864-017-4133-4] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Identifying rare germline and somatic variants associated with cancer progression is an important research topic in cancer genomics. Although many approaches are proposed for rare variant association study, they are not fit for cancer sequencing data due to multiple issues, such as overly relying on pre-selection, losing sight of interacting hotspots, etc. RESULTS In this article, we propose an improved pipeline to identify germline variant and somatic mutation interactions influencing cancer susceptibility from pair-wise cancer sequencing data. The proposed pipeline, RareProb-C performs an algorithmic selection on the given variants by incorporating the variant allelic frequencies. The interactions among the variants are considered within the regions which are limited by a four-gamete test. Then it filters singular cases according to the posterior probability at each site. Finally, it outputs the selected candidates that pass a collapse test. CONCLUSIONS We apply RareProb-C on a series of carefully constructed simulation cases and it outperforms six existing genetic model-free approaches. We also test RareProb-C on 429 TCGA ovarian cancer cases, and RareProb-C successfully identifies the known highlighted variants which are considered increasing disease susceptibilities.
Collapse
Affiliation(s)
- Yu Geng
- School of Electronic and Information Engineering, Xi'an Jiaotong University, Xi'an, 710049, Shaanxi, China.,Jinzhou Medical University, Jinzhou, Liaoning, 121001, China
| | - Zhongmeng Zhao
- School of Electronic and Information Engineering, Xi'an Jiaotong University, Xi'an, 710049, Shaanxi, China. .,Institute of Data Science and Information Quality, Shaanxi Engineering Research Center of Medical and Health Big Data, Xi'an Jiaotong University, Xi'an, 710049, Shaanxi, China.
| | - Xuanping Zhang
- School of Electronic and Information Engineering, Xi'an Jiaotong University, Xi'an, 710049, Shaanxi, China.,Institute of Data Science and Information Quality, Shaanxi Engineering Research Center of Medical and Health Big Data, Xi'an Jiaotong University, Xi'an, 710049, Shaanxi, China
| | - Wenke Wang
- School of Electronic and Information Engineering, Xi'an Jiaotong University, Xi'an, 710049, Shaanxi, China
| | - Xingjian Cui
- School of Electronic and Information Engineering, Xi'an Jiaotong University, Xi'an, 710049, Shaanxi, China.,Institute of Data Science and Information Quality, Shaanxi Engineering Research Center of Medical and Health Big Data, Xi'an Jiaotong University, Xi'an, 710049, Shaanxi, China
| | - Kai Ye
- School of Electronic and Information Engineering, Xi'an Jiaotong University, Xi'an, 710049, Shaanxi, China.,Institute of Data Science and Information Quality, Shaanxi Engineering Research Center of Medical and Health Big Data, Xi'an Jiaotong University, Xi'an, 710049, Shaanxi, China
| | - Xiao Xiao
- Institute of Data Science and Information Quality, Shaanxi Engineering Research Center of Medical and Health Big Data, Xi'an Jiaotong University, Xi'an, 710049, Shaanxi, China.,State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Xi'an, 710032, Shaanxi, China
| | - Jiayin Wang
- School of Management, Xi'an Jiaotong University, Xi'an, 710049, Shaanxi, China. .,Institute of Data Science and Information Quality, Shaanxi Engineering Research Center of Medical and Health Big Data, Xi'an Jiaotong University, Xi'an, 710049, Shaanxi, China.
| |
Collapse
|
3
|
Bonate PL. Estimation of QT interval prolongation through model-averaging. J Pharmacokinet Pharmacodyn 2017; 44:335-349. [PMID: 28421417 DOI: 10.1007/s10928-017-9523-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2016] [Accepted: 04/05/2017] [Indexed: 10/19/2022]
Abstract
The current method to analyze concentration-QT interval data, which is based on predictions conditional on a best model, fails to take into account the uncertainty of the model. Previous studies have suggested that failure to take into account model uncertainty using a best model approach can result in confidence intervals that are overly optimistic and may be too narrow. Theoretically, more realistic estimates are obtained using model-averaging where the overall point estimate and confidence interval are a weighted-average from a set of candidate models, the weights of which are equal to each model's Akaike weight. Monte Carlo simulation was used to determine the degree of narrowness in the confidence interval for the degree of QT prolongation under a single ascending dose and thorough QT trial design. Results showed that model averaging performed as well as the best model approach under most conditions with no numeric advantage to using a model averaging approach. No difference was observed in the coverage of the confidence intervals when the best model and model averaging was done by AIC, AICc, or BIC, although in certain circumstances the coverage of the confidence interval themselves tended to be too narrow when using BIC. Modelers can continue to use the best model approach for concentration-QT modeling with confidence, although model averaging may offer more face validity, may be of value in cases where there is uncertainty or misspecification in the best model, and be more palatable to a non-technical reviewer than the best model approach.
Collapse
Affiliation(s)
- Peter L Bonate
- Astellas, 1 Astellas Way, N2.184, Northbrook, IL, 60062, USA.
| |
Collapse
|
4
|
Fu J, Beaty TH, Scott AF, Hetmanski J, Parker MM, Wilson JEB, Marazita ML, Mangold E, Albacha-Hejazi H, Murray JC, Bureau A, Carey J, Cristiano S, Ruczinski I, Scharpf RB. Whole exome association of rare deletions in multiplex oral cleft families. Genet Epidemiol 2017; 41:61-69. [PMID: 27910131 PMCID: PMC5154821 DOI: 10.1002/gepi.22010] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2016] [Revised: 09/21/2016] [Accepted: 09/21/2016] [Indexed: 11/11/2022]
Abstract
By sequencing the exomes of distantly related individuals in multiplex families, rare mutational and structural changes to coding DNA can be characterized and their relationship to disease risk can be assessed. Recently, several rare single nucleotide variants (SNVs) were associated with an increased risk of nonsyndromic oral cleft, highlighting the importance of rare sequence variants in oral clefts and illustrating the strength of family-based study designs. However, the extent to which rare deletions in coding regions of the genome occur and contribute to risk of nonsyndromic clefts is not well understood. To identify putative structural variants underlying risk, we developed a pipeline for rare hemizygous deletions in families from whole exome sequencing and statistical inference based on rare variant sharing. Among 56 multiplex families with 115 individuals, we identified 53 regions with one or more rare hemizygous deletions. We found 45 of the 53 regions contained rare deletions occurring in only one family member. Members of the same family shared a rare deletion in only eight regions. We also devised a scalable global test for enrichment of shared rare deletions.
Collapse
Affiliation(s)
- Jack Fu
- Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore MD, USA
| | - Terri H. Beaty
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore MD, USA
| | - Alan F. Scott
- Center for Inherited Disease Research and Institute of Genetic Medicine, Johns Hopkins School of Medicine, Baltimore MD, USA
| | - Jacqueline Hetmanski
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore MD, USA
| | - Margaret M. Parker
- Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston MA, USA
| | - Joan E. Bailey Wilson
- Inherited Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Baltimore MD, USA
| | - Mary L. Marazita
- Department of Oral Biology, Center for Craniofacial and Dental Genetics, School of Dental Medicine, University of Pittsburgh, PA, USA
| | | | | | - Jeffrey C. Murray
- Department of Pediatrics, School of Medicine, University of Iowa, IA, USA
| | - Alexandre Bureau
- Centre de Recherche de l’Institut Universitaire en Santé Mentale de Québec and Département de Médecine Sociale et Préventive, Université Laval, Québec, Canada
| | - Jacob Carey
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore MD, USA
| | - Stephen Cristiano
- Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore MD, USA
| | - Ingo Ruczinski
- Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore MD, USA
| | - Robert B. Scharpf
- Department of Oncology, Johns Hopkins School of Medicine, Baltimore MD, USA
| |
Collapse
|